(+)-α-Tocopherol NHS succinate 37925 Anticancer Research: TCS 359 is

Anticancer Research: TCS 359 is being studied for its efficacy in inhibiting cancer cell growth

3R)-(+)-N-Boc-6-oxo-2

providing hydration and improving the texture of creams and lotions

it acts as an intermediate in synthesizing various active pharmaceutical ingredients (APIs)

Pharmaceutical Development: It is used in the pharmaceutical industry for the preparation of active pharmaceutical ingredients (APIs)

(+)-α-Tocopherol NHS succinate 37925 Anticancer Research: TCS 359 is(+) a Tocopherol NHS succinate is widely utilized in research focused on: Drug Delivery Systems: This compound is often used to enhance the solubility and bioavailability of poorly soluble drugs, making it valuable in pharmaceutical formulations. Antioxidant Applications: Its antioxidant properties help in protecting cells from oxidative stress, which is crucial in developing supplements and functional foods. Cosmetic Formulations: The compound is